Moreira, D M
Nickel, J C
Andriole, G L
Castro-Santamaria, R
Freedland, S J
Article History
Received: 12 October 2015
Revised: 27 November 2015
Accepted: 2 December 2015
First Online: 19 January 2016
Competing interests
: RC-S is employed by GlaxoSmithKline. SJF has received a grant from GlaxoSmithKline. JCN has acted as a consultant for GlaxoSmithKline, Pfizer, Astellas and Lilly. He has provided expert testimony for GlaxoSmithKline and has received a grant from the company for the BPH Prostatitis Investigator-Initiated Study. GLA has received a grant from GlaxoSmithKline as well as a consulting fee for acting as chair of the REDUCE Steering Committee. He has also acted as a consultant for Bayer, Genomic Health, GlaxoSmithKline and Myriad Genetics. DMM declares no conflict of interest.